Simultaneous Sinus Floor Elevation and Implant Placement Using Leukocyte- and Platelet-Rich Fibrin as a Sole Graft Material

Molemans, Bo; Cortellini, Simone; Jacobs, Reinhilde; Pinto, Nelson; Teughels, Wim; Quirynen, Marc

doi:10.11607/jomi.7371

Cited by 32 publications

(33 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…When PRF alone is used with simultaneous implant placement vertical bone gain after six months is substantial: 10.1 mm [ 27 ], 10.4 mm [ 28 ], or 11.8 mm [ 29 ]. The histological samples confirmed new bone formation in case of sinus lift with PRF alone in both situations, with and without simultaneous implantations [ 30 ], and proved that PRF as a sole graft material during sinus floor augmentation induces natural bone regeneration [ 31 ].…”

Section: Discussionmentioning

confidence: 94%

See 1 more Smart Citation

Maxillary Sinus Floor Augmentation to Enable One-Stage Implant Placement by Using Bovine Bone Substitute and Platelet-Rich Fibrin

Barbu

Andreescu

Comăneanu

et al. 2018

BioMed Research International

View full text Add to dashboard Cite

Nowadays it is possible to perform an optimal implant placement and to achieve a good long-term prognosis for an implant-borne prosthesis in the grafted posterior maxilla. This study evaluates the efficiency of one-stage piezosurgery by using as graft material a combination of particulate bovine bone substitutes with platelet-rich fibrin to achieve sinus lift. We included in this study 14 cases of one-stage sinus lift surgeries during which we placed 30 standard implants. The mean vertical bone height gain was 10.12 mm six months after surgery, and the mean postoperative follow-up time was 43.79 months. There were no major complications during or after surgery, and all implants are in use. Therefore, it can be concluded that one-stage sinus piezosurgery using particulate bovine bone substitutes and platelet-rich fibrin can be applied as a predictable and effective technique in the treatment of the posterior edentulous maxilla ensuring 4-5 mm vertical bone height.

show abstract

Section: Discussionmentioning

confidence: 94%

“…PRF alone can be used for sinus floor augmentation as mentioned in several studies [ 27 – 31 ]. When PRF alone is used with simultaneous implant placement vertical bone gain after six months is substantial: 10.1 mm [ 27 ], 10.4 mm [ 28 ], or 11.8 mm [ 29 ].…”

Section: Discussionmentioning

confidence: 99%

Maxillary Sinus Floor Augmentation to Enable One-Stage Implant Placement by Using Bovine Bone Substitute and Platelet-Rich Fibrin

Barbu

Andreescu

Comăneanu

et al. 2018

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Anitua et al [53] reported a mean bone height of 8.8 ± 1.4 mm and a mean bone gain of 4.3 ± 2.0 mm using plasma-rich in growth factors (PRGF) as the only graft material after three years of follow-up in an immediate protocol for short implant placement. Mean bone gain in the other studies varied between a minimum of 3.2-3.4 mm [66][67][68] and a maximum of 10 mm [58,60]. Kanayama et al [46] reported a statistically significant mean bone gain in sandblasted acid-etched implants compared to hydroxyapatite implants, and Molemans et al [67] reported a higher mean bone gain (5.4 ± 1.5 mm) with the lateral sinus floor elevation approach versus the transalveolar technique (3.4 ± 1.2 mm).…”

Section: Sole Use Of Platelet Concentrates In Sinus Floor Augmentationmentioning

confidence: 89%

“…Mean bone gain in the other studies varied between a minimum of 3.2-3.4 mm [66][67][68] and a maximum of 10 mm [58,60]. Kanayama et al [46] reported a statistically significant mean bone gain in sandblasted acid-etched implants compared to hydroxyapatite implants, and Molemans et al [67] reported a higher mean bone gain (5.4 ± 1.5 mm) with the lateral sinus floor elevation approach versus the transalveolar technique (3.4 ± 1.2 mm). Two studies additionally reported similar mean bone height values of 11.5 mm after six months of follow-up [47,65] (Table 1).…”

Section: Sole Use Of Platelet Concentrates In Sinus Floor Augmentationmentioning

confidence: 89%

See 1 more Smart Citation

Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review

et al. 2020

View full text Add to dashboard Cite

Background: Sinus augmentation can be performed with or without grafting biomaterials, and to date, there is no quality evidence regarding the augmentation of the sinus floor using only platelet concentrates, which can improve the healing period and enhance bone regeneration by stimulating angiogenesis and bone formation. The main objective of this paper was to assess the effect of the sole use of platelet concentrates in sinus augmentation in terms of newly formed bone, augmented bone height, and clinical outcomes and to assess the additional beneficial effects of platelet-rich fibrin (PRF) in combination with other grafting biomaterials. Methods: A systematic review was conducted following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Pooled analyses were performed with the Review Manager software. Results: For sinus elevation only using platelet concentrates, 11 studies met the inclusion criteria and were included for qualitative synthesis. Only one study was a clinical trial, which reported improved outcomes for the allograft group compared to the titanium-PRF (T-PRF) group. A total of 12 studies where PRF was used in addition to grafting biomaterials met eligibility criteria and were included in the review. Results from meta-analyses provided no additional beneficial effects of PRF in sinus augmentation in terms of bone height and percentage of soft tissue area. There was a statistically significant lower percentage of residual bone substitute material in the PRF (+) group compared to the PRF (−) group. The percentage of newly formed bone was slightly higher in the PRF (+) group, but this was not statistically significant. Conclusion: There is no robust evidence to make firm conclusions regarding the beneficial effects of the sole use of platelet concentrates in sinus augmentation. However, studies have shown favorable outcomes regarding implant survival, bone gain, and bone height. The use of PRF with other grafting biomaterials appears to provide no additional beneficial effects in sinus lift procedures, but they may improve the healing period and bone formation. Well-conducted randomized clinical trials (RCTs) are necessary to confirm the available results to provide recommendations for the clinical practice.

show abstract

Platelet‐Rich Fibrin for Bone Augmentation in Implant Dentistry

2022

Essential Techniques of Alveolar Bone Augmentation in Implant Dentistry

View full text Add to dashboard Cite

Simultaneous Sinus Floor Elevation and Implant Placement Using Leukocyte- and Platelet-Rich Fibrin as a Sole Graft Material

Cited by 32 publications

References 30 publications

Maxillary Sinus Floor Augmentation to Enable One-Stage Implant Placement by Using Bovine Bone Substitute and Platelet-Rich Fibrin

Maxillary Sinus Floor Augmentation to Enable One-Stage Implant Placement by Using Bovine Bone Substitute and Platelet-Rich Fibrin

Platelet-Rich Plasma in Maxillary Sinus Augmentation: Systematic Review

Platelet‐Rich Fibrin for Bone Augmentation in Implant Dentistry

Contact Info

Product

Resources

About